Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Organocatalyzed [4 + 2] cycloaddition of α,β-unsaturated ketones and isatylidene malononitrile: accessing spiro[3-arylcyclohexanone]oxindole derivatives

Baliram R. Patilab, Chandrakant B. Nichindeab, Suryakant S. Chaudhariab, Gamidi Rama Krishnac and Anil K. Kinage*ab
aChemical Engineering and Process Development Division, Council of Scientific and Industrial Research-National Chemical Laboratory (CSIR-NCL), Pune 411008, India. E-mail: ak.kinage@ncl.res.in
bAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
cOrganic Chemistry Division, Council of Scientific and Industrial Research-National Chemical Laboratory (CSIR-NCL), Pune 411008, India

Received 9th November 2023 , Accepted 29th December 2023

First published on 17th January 2024


Abstract

Herein, we developed a series of compounds featuring spiro[3-arylcyclohexanone]oxindoles through Barbas [4 + 2] cycloaddition reactions between isatylidene malononitrile and α,β-unsaturated ketones using L-proline as an organocatalyst. The reported methodology offers many advantages such as mild reaction conditions, diverse substrate scope with high yields, easy reaction setup, and use of easily synthesizable starting materials.


Introduction

In the construction of complex organic molecules, cascade reactions are a potent tool that enable the creation of complex structures from relatively abundant small molecules.1 The Barbas [4 + 2] cycloaddition reaction enables highly efficient C–C bond formation reactions, involving amino acid- or amine-catalyzed cycloaddition reactions between 2-aminobuta-1,3-diene and activated olefins.2 The organocatalyzed cyclization of isatin derivatives has driven extraordinary progress in cascade or tandem reactions, facilitating the construction of diverse molecular frameworks, particularly spirooxindoles.3 These motifs are found in natural products such as alkaloids, important pharmaceutical molecules, biologically active compounds, and even synthetic drugs that demonstrate a wide range of biological activities.4 Notably, these spirooxindole structures hold great promise in drug development, exhibiting potential in areas such as anti-HIV, anti-cancer, and anti-tubercular applications.5 Among spirooxindole derivatives, cyclohexaneoxindoles are the most important structural skeletons because they are found in a wide range of biologically active compounds, such as natural alkaloid gelsemine,6 MDM2-p53 inhibitor,7 NITD609, and exhibit promising therapeutic use against malaria,8 satavaptan,9 nonsteroidal progesterone receptor modular,10 spindomycine,11 etc.

We have recently developed a novel organo-catalyzed one-pot strategy for the efficient synthesis of 3,3′-disubstituted oxindoles featuring an all-carbon quaternary center and spiro[2H-pyran-3,4′-indoline].12 Later, we realized that the extension of the methodology also opened up opportunities for the synthesis of spiro[3-arylcyclohexanone]oxindole derivatives with potential biological significance (Fig. 1).


image file: d3ra07652k-f1.tif
Fig. 1 Representative biologically active compounds with spirocyclohexaneoxin-dole skeletons.

Substantial efforts have been made for the construction of spirocyclohexaneoxindole skeletons, such as through the double Michael addition reaction,13 organocatalytic Michael/Michael/Aldol addition reaction,14 Michael/Povarov reaction,15 Michael/Aldol reaction,16 and Barbas [4 + 2]cycloaddition reaction.2

L-Proline-catalyzed reactions have been successfully applied for the construction of C–C bond and C–heteroatom bonds.17 However, to the best of our knowledge so far, the L-proline-catalyzed Barbas [4 + 2] cycloaddition reaction has not been reported in the literature, especially for the synthesis of spiro[3-arylcyclohexanone] oxindoles. Therefore, we herein report the synthesis of spiro[3-arylcyclohexanone]oxindole derivatives from the L-proline-catalyzed Barbas [4 + 2] cycloaddition of α,β-unsaturated ketones and isatylidene malononitrile using ethanol as a green solvent.

Result and discussion

We initiated our preliminary investigation by employing isatylidene malononitrile (1a) as an appropriate Michael acceptor and benzylideneacetone (2a) as a model starting material. From our previous experience for the L-proline-catalyzed one-pot synthesis of 3,3-disubstituted oxindole in ethanol solvent, our optimization initiative commenced by using ethanol as the solvent. We started our reaction with various amine catalysts by visualizing the formation of an enamine (Michael donner) from benzylideneacetone (2a).

Under the catalyst-free condition, the formation of the product (3Aa) was not observed (Table 1; entry 1). Then, we used pyrrolidine (C1) as the catalyst and observed that the reaction was slower with a low yield of 35% (Table 1; entry 2). In case of piperidine (C2) as the catalyst, the reaction worked better than for pyrrolidine and the yield was improved to 63% (Table 1; entry 3). Furthermore, when we examined the reaction using morpholine (C3) as the catalyst, the rate of reaction was again slower and the product yield also decreased (Table 1; entry 4). Then, we tried the reaction with piperidine (C2) and the monochloroacetic acid additive and observed that the additive had no effect on the yield (Table 1; entry 5). Then, we moved toward the use of amino acids as the catalyst, and we first tried the reaction with L-proline as the catalyst and we obtained a 76% yield in 10 h with a diastereomeric ratio of 1[thin space (1/6-em)]:[thin space (1/6-em)]2 (Table 1; entry 6). Then, to improve the dr of product 3, we tried a bulky amino acid amide18 (C5) as the catalyst and observed that the reaction required a longer time and the yield was low. Moreover, no improvement in dr was observed (Table 1; entry 7). Finally, we tried the reaction with an amino acid amide ionic liquid (C6) and found that the reaction proceeded very slow with a very poor yield, as well as no improvement in dr (Table 1; entry 8). From the screening of all the above catalysts, we found that L-proline was an effective catalyst for this reaction. With the best catalyst in hand, we next aimed to optimize the catalyst loading for the reaction. We lowered the catalyst loading to 15 and 10 mol%; however, the reaction took a longer time compared to the optimized catalyst loading of 20 mol% with a low yield (Table 1; entries 9 and 10). With the optimized catalyst loading, we next checked the effect of ketone 2a on the reaction and the use of 1.5 equiv. of 2a we obtained an excellent yield within 8 h (Table 1; entry 11). Further, we added 2 equiv. of 2a, but we obtained the same result (Table 1; entry 12). Next, various solvents, such as methanol (MeOH), dichloromethane (DCM), acetonitrile (ACN), dichloroethane (DCE), tetrahydrofuran (THF), dimethylformamide (DMF), 1,4-dioxane (dioxane), dimethyl sulfoxide (DMSO), and toluene were examined with an aim to improve the dr of the product, but unfortunately there was no improvement in yield as well as dr (Table 1; entries 13 to 21). Finally, we performed the reaction at different temperatures to check the effect of temperature on the reaction. At 0 °C, the reaction rate was slower with no improvement in dr (Table 1; entry 22), and at reflux conditions at 80 °C, we observed a lower yield with some decomposition (Table 1; entry 23).

Table 1 Optimization of the reaction conditionsa

image file: d3ra07652k-u1.tif

Entry Catalyst (mol%) Solvent (1 ml) Time (h) drf Yieldb (%)
a Unless otherwise noted, all the reactions were performed with 1 (0.5 mmol, 1 equiv.), 2 (0.55 mmol, 1.1 equiv.) and the catalyst (20 mol%) in the mentioned solvent (1 ml).b Isolated yield of two diastereomers.c Added monochloro acetic acid (40 mol%).d 2 (0.75 mmol, 1.5 equiv.).e 2 (1 mmol, 2 equiv.).f dr of the product calculated by 1H NMR of the crude product.g Reaction at 0 °C.h Reflux reaction at 80 °C.
1 EtOH 48 N.R.
2 C1 (20) EtOH 24 1[thin space (1/6-em)]:[thin space (1/6-em)]1 35
3 C2 (20) EtOH 10 1[thin space (1/6-em)]:[thin space (1/6-em)]1 63
4 C3 (20) EtOH 16 1[thin space (1/6-em)]:[thin space (1/6-em)]1 50
5c C2 (20) EtOH 9 1[thin space (1/6-em)]:[thin space (1/6-em)]1 61
6 C4 (20) EtOH 10 1[thin space (1/6-em)]:[thin space (1/6-em)]2 76
7 C5 (20) EtOH 150 1[thin space (1/6-em)]:[thin space (1/6-em)]2 50
8 C6 (20) EtOH 170 1[thin space (1/6-em)]:[thin space (1/6-em)]2 20
9 C4 (10) EtOH 14 1[thin space (1/6-em)]:[thin space (1/6-em)]2 61
10 C4 (15) EtOH 10.5 1[thin space (1/6-em)]:[thin space (1/6-em)]2 69
11d C4 (20) EtOH 8 1[thin space (1/6-em)]:[thin space (1/6-em)]2 92
12e C4 (20) EtOH 8 1[thin space (1/6-em)]:[thin space (1/6-em)]2 92
13 C4 (20) MeOH 35 1[thin space (1/6-em)]:[thin space (1/6-em)]2 82
14 C4 (20) DCM 48 1[thin space (1/6-em)]:[thin space (1/6-em)]1.5 68
15 C4 (20) ACN 48 1[thin space (1/6-em)]:[thin space (1/6-em)]1 20
16 C4 (20) DCE 130 1[thin space (1/6-em)]:[thin space (1/6-em)]1.5 76
17 C4 (20) THF 52 1[thin space (1/6-em)]:[thin space (1/6-em)]1 58
18 C4 (20) DMF 50 1[thin space (1/6-em)]:[thin space (1/6-em)]2 <30
19 C4 (20) 1,4-Dioxane 42 1[thin space (1/6-em)]:[thin space (1/6-em)]1.8 40
20 C4 (20) DMSO 53 1[thin space (1/6-em)]:[thin space (1/6-em)]2 55
21 C4 (20) Toluene 130 1[thin space (1/6-em)]:[thin space (1/6-em)]1 75
22g C4 (20) EtOH 36 1[thin space (1/6-em)]:[thin space (1/6-em)]2 90
23h C4 (20) EtOH 6 1[thin space (1/6-em)]:[thin space (1/6-em)]2 42


With the optimized reaction conditions in hand, our focus next was to check the efficiency of the methodology across a more extensive substrate scope. Initially we checked isatylidene malononitriles with the electron-donating groups 5-Me and 5-OMe, which gave the corresponding product in good yields but with a poor dr up to 1[thin space (1/6-em)]:[thin space (1/6-em)]2 (3Ab, 3Ac). Isatylidene malononitriles with a halogen substitute at different positions (5-Cl, 5-Br, 4-Br, 6-Cl, 6-Br, 7-F, and 7-Cl) were next studied and showed excellent yields up to 85–90% with dr up to 1[thin space (1/6-em)]:[thin space (1/6-em)]3 (3Ad–3Aj). Further we checked isatylidene malononitriles with electron-withdrawing groups such as 5-OCF3 (3Ak 93% yield, 1[thin space (1/6-em)]:[thin space (1/6-em)]2 dr) and 5-NO2 (3Al 94% yield, 1[thin space (1/6-em)]:[thin space (1/6-em)]2 dr), and the reaction worked smoothly. When comparing the reaction rate of the substrates with electron-withdrawing groups and electron-donating groups, it was observed that the rate of reaction was faster with electron-withdrawing groups (Scheme 1).


image file: d3ra07652k-s1.tif
Scheme 1 Substrate scope for the synthesis of spiro[3-arylcyclohexanone] oxindoles. Reaction condition: all the reactions were performed in reaction tubes with 1 (0.5 mmol, 1 equiv.), 2 (0.75 mmol, 1.5 equiv.), and L-proline (20 mol%) in ethanol (1 ml) at rt. Yields given here are for the addition of two diastereomers. dr values mentioned above were calculated by 1H NMR of the crude product. Yields shown above are the combined yields of two diastereomers. We separated the two diastereomers by silica gel column chromatography and the ESI characterizations provided are for the major diastereomer only.

Then, we tried the reaction with various N-alkyl-substituted isatylidene malononitrile-like derivatives, such as N-methyl, N-ethyl, N-butyl, N-isopropyl, N-isobutyl, N-cyclopentyl, N-benzyl, and N-ethyl phenyl, and all worked well with high to excellent yields and dr of up to 1[thin space (1/6-em)]:[thin space (1/6-em)]3 (3Ba–3Bh, yields from 82–92%, 1[thin space (1/6-em)]:[thin space (1/6-em)]1–1[thin space (1/6-em)]:[thin space (1/6-em)]3 dr). Isatylidene malononitriles with N-allyl and N-propargyl substrates reacted slowly to give high yields (3Bi and 3Bj). In case of N-Boc isatylidene malononitriles, the reaction worked well with a high yield (3Bk, yield 79%, 1[thin space (1/6-em)]:[thin space (1/6-em)]2 dr). The optimized reaction conditions also worked for N-phenyl isatylidene malononitrile to give a high yield and 1[thin space (1/6-em)]:[thin space (1/6-em)]3 dr (3Bl). For more confirmation of the products, we performed single-crystal X-ray analysis for compounds 3Ac and 3Bd, as shown in Fig. 2.


image file: d3ra07652k-f2.tif
Fig. 2 ORTEP diagrams for compounds 3Ac and 3Bd.

Finally, we explored the reaction with various α,β-unsaturated acetones, and all worked smoothly under the optimized reaction conditions. We started from the β-phenyl group with alkyl substitutions, like p-methyl, p-ethyl, p-isopropyl α,β-unsaturated acetone, which all gave high yields and dr up to 1[thin space (1/6-em)]:[thin space (1/6-em)]3 (3Ca–3Cc). Further, we checked the β-phenyl group with electron-donating groups on the phenyl ring, like p-OMe and o-,m′-DiOMe, and we got the corresponding product with high yields (3Cd and 3Ce, yields 85% and 83%, dr up to 1[thin space (1/6-em)]:[thin space (1/6-em)]2). Then, we checked the efficiency of the methodology with halogen substitute β-phenyl groups, like o-F, o-Cl, o-Br, m-Cl, and p-F, and all gave the corresponding product with high to excellent yields (3Cf–3Cj, yields from 86–90%, dr up to 1[thin space (1/6-em)]:[thin space (1/6-em)]2). With electron-withdrawing groups on the β-phenyl group like o-CF3 and p-NO2, the reaction gave excellent yields with dr up to 1[thin space (1/6-em)]:[thin space (1/6-em)]3.5 (3Ck and 3Cl).

After conducting the reaction with various α,β-unsaturated acetones, we observed that the β-phenyl group (electron-withdrawing groups) reacted faster than the case with electron-donating or halo-substituted β-phenyl groups. Further, we checked the reaction with a β-naphthyl group, affording the corresponding product with a 90% yield and with dr 1[thin space (1/6-em)]:[thin space (1/6-em)]4 (3Cm). A β-heteroaryl group like furan also worked under the optimized reaction conditions and gave an 80% yield and dr of 1[thin space (1/6-em)]:[thin space (1/6-em)]4.5 (3Cn). Ultimately, we checked the efficiency of the methodology with a β-methyl group and it worked well and gave a 78% yield with dr of 1[thin space (1/6-em)]:[thin space (1/6-em)]4 (3Co).

On the basis of the previously reported related mechanistic research,2a,b we propose a plausible mechanism based on the Barbas [4 + 2] cycloaddition reaction, as illustrated in Fig. 3. Here, initially, L-proline (Cat.) reacts with benzylideneacetone (2a), leading to the formation of enamine via carbinolamine and iminium-ion intermediates. This enamine functions as 2-aminobuta-1,3-diene (Diene). Simultaneously, isatylidene malononitrile acts as a dienophile in the [4 + 2] cycloaddition, affording a [4 + 2] adduct. With the formal [4 + 2] cycloaddition it offers, subsequent hydrolysis of the adduct yields spiro[3-arylcyclohexanone]oxindoles, with the regeneration of L-proline for the next catalyst cycle.


image file: d3ra07652k-f3.tif
Fig. 3 Plausible reaction mechanism.

Conclusion

In summary, we developed an efficient methodology for the construction of spiro[3-arylcyclohexanone]oxindoles derivative via a Barbas [4 + 2] cycloaddition reaction of isatylidene malononitrile and α,β-unsaturated ketones using L-proline as a catalyst. The presented synthetic protocol offers many advantages, including the use of easily synthesizable starting materials from cheaply available materials, operational simplicity with an easy reaction setup, and the final product achieved in high to excellent yields with poor to moderate diastereoselectivity. Research for asymmetric expansion of this methodology is ongoing in our laboratory.

Author contributions

B. R. P. Perform the experiment and developed the method. S. S. C. expanded the substrate scope. B. R. P. and C.·B. N. wrote main manuscript, ESI and analyzed data, A. K. K. directed the project. G. R. K. performed the single-crystal X-ray data analysis.

Conflicts of interest

The authors declare no competing financial interest.

Acknowledgements

B. R. P. and S. S. C. thanks, UGC for a SRF fellowship. C. B. N. thanks CSIR-New Delhi, India, for the SRF fellowship. The support from central NMR, HRMS facility, single-crystal X-ray facility and CSIR-NCL is greatly acknowledged.

References

  1. (a) K. C. Nicolaou, T. Montagnona and S. A. Snyder, Chem. Commun., 2003, 551–564 RSC; (b) K. C. Nicolaou, D. J. Edmonds and P. G. Bulger, Angew. Chem., Int. Ed., 2006, 45, 7134–7186 CrossRef CAS PubMed; (c) K. C. Nicolaou and J. S. Chen, Chem. Soc. Rev., 2009, 38, 2993–3009 RSC; (d) C. Grondal, M. Jeanty and D. Enders, Nat. Chem., 2010, 2, 167–178 CrossRef CAS PubMed; (e) R. Ardkhean, D. F. J. Caputo, S. M. Morrow, H. Shi, Y. Xiong and E. A. Anderson, Chem. Soc. Rev., 2016, 45, 1557–1569 RSC.
  2. (a) D. B. Ramachary, P. S. Reddy, K. S. Shruthi, R. Madhavachary and P. V. G. Reddy, Eur. J. Org Chem., 2016, 5220–5226 CrossRef CAS; (b) R. Thayumanavan, D. B. Ramachary, K. Sakthivel, F. Tanaka and C. F. Barbas III, Tetrahedron Lett., 2002, 43, 3817–3820 CrossRef CAS; (c) D. B. Ramachary, N. S. Chowdari and C. F. Barbas III, Tetrahedron Lett., 2002, 43, 6743–6746 CrossRef CAS; (d) D. B. Ramachary, N. S. Chowdari and C. F. Barbas III, Synlett, 2003, 1910–1914 CAS; (e) D. B. Ramachary, K. Anebouselvy, N. S. Chowdari and C. F. Barbas III, J. Org. Chem., 2004, 69, 5838–5849 CrossRef CAS PubMed; (f) D. B. Ramachary, N. S. Chowdari and C. F. Barbas III, Angew. Chem., Int. Ed., 2003, 42, 4233–4237 CrossRef CAS PubMed; (g) D. B. Ramachary and C. F. Barbas III, Chem.–Eur. J., 2004, 10, 5323–5331 CrossRef CAS PubMed; (h) D. B. Ramachary and C. F. Barbas III, Org. Lett., 2005, 7, 1577–1580 CrossRef CAS PubMed.
  3. (a) X. H. Chen, Q. Wei, S. W. Luo, H. Xiao and L. Z. Gong, J. Am. Chem. Soc., 2009, 131, 13819–13825 CrossRef CAS PubMed; (b) Y. M. Cao, X. X. Jiang, L. P. Liu, F. F. Shen, F. T. Zhang and R. Wang, Angew. Chem., Int. Ed., 2011, 50, 9124–9127 CrossRef CAS PubMed; (c) B. Tan, N. R. Candeias and C. F. Barbas III, Nat. Chem., 2011, 3, 473–477 CrossRef CAS PubMed; (d) G. Bencivenni, L. Y. Wu, A. Mazzanti, B. Giannichi, F. Pesciaioli, M. P. Song, G. Bartoli and P. Melchiorre, Angew. Chem., Int. Ed., 2009, 48, 7200–7203 CrossRef CAS PubMed; (e) Y. B. Lan, H. Zhao, Z. M. Liu, G. G. Liu, J. C. Tao and X. W. Wang, Org. Lett., 2011, 13, 4866–4869 CrossRef CAS PubMed; (f) Q. Wei and L. Z. Gong, Org. Lett., 2010, 12, 1008–1011 CrossRef CAS PubMed; (g) K. Jiang, Z. J. Jia, S. Chen, L. Wu and Y. C. Chen, Chem.–Eur. J., 2010, 16, 2852–2856 CrossRef CAS PubMed; (h) F. Pesciaioli, P. Righi, A. Mazzanti, G. Bartoli and G. Bencivenni, Chem.–Eur. J., 2011, 17, 2842–2845 CrossRef CAS PubMed; (i) L. H. Sun, L. T. Shen and S. Ye, Chem. Commun., 2011, 47, 10136–11038 RSC; (j) C. V. Galliford and K. A. Scheidt, Angew. Chem., Int. Ed., 2007, 46, 8748–8758 CrossRef CAS PubMed; (k) F. Zhou, Y. L. Liu and J. Zhou, Adv. Synth. Catal., 2010, 352, 1381–1407 CrossRef CAS; (l) G. S. Singh and Z. Y. Desta, Chem. Rev., 2012, 112, 6104–6155 CrossRef CAS PubMed; (m) N. R. Ball-Jones, J. J. Badillo and A. K. Franz, Org. Biomol. Chem., 2012, 10, 5165–5181 RSC.
  4. (a) B. M. Trost and M. K. Brennan, Synthesis, 2009, 3003–3025 CrossRef CAS; (b) F. Zhou, Y. L. Liu and J. Zhou, Adv. Synth. Catal., 2010, 352, 1381–1407 CrossRef CAS; (c) M. M.-C. Lo, C. S. Neumann, S. Nagayama, E. O. Perlstein and S. L. Schreiber, J. Am. Chem. Soc., 2004, 126, 16077–16086 CrossRef CAS PubMed.
  5. (a) S. Peddibhotla, Curr. Bioact. Compd., 2009, 5, 20–38 CrossRef CAS; (b) C. V. Galliford and K. A. Scheidt, Angew. Chem., Int. Ed., 2007, 46, 8748–8758 CrossRef CAS PubMed; (c) T. J. Greshock, A. W. Grubbs, P. Jiao, D. T. Wicklow, J. B. Gloer and R. M. Williams, Angew. Chem., Int. Ed., 2008, 47, 3573–3577 CrossRef CAS PubMed.
  6. H. Lin, S. J. Danishefsky, S. J. Danishefsky and H. Lin, Angew. Chem., Int. Ed., 2003, 42, 36–51 CrossRef CAS PubMed.
  7. Y. Zhao, A. Aguilar, D. Bernard and S. Wang, J. Med. Chem., 2015, 58, 1038–1052 CrossRef CAS PubMed.
  8. M. Rottmann, C. McNamara, B. K. S. Yeung, M. C. S. Lee, B. Zou, B. Russell, P. Seitz, D. M. Plouffe, N. V. Dharia and J. Tan, et al., Science, 2010, 329, 1175–1180 CrossRef CAS PubMed.
  9. H. Venkatesan, M. C. Davis, Y. Altas, J. P. Snyder and D. C. Liotta, J. Org. Chem., 2001, 66, 3653–3661 CrossRef CAS PubMed.
  10. T. I. Richardson, C. A. Clarke, K.-L. Yu, Y. K. Yee, T. J. Bleisch, J. E. Lopez, S. A. Jones, N. E. Hughes, B. S. Muehl, C. W. Lugar, T. L. Moore, P. K. Shetler, R. W. Zink, J. J. Osborne, C. Montrose-Rafizadeh, N. Patel, A. G. Geiser, R. J. S. Galvin and J. A. Dodge, ACS Med. Chem. Lett., 2011, 2, 148–153 CrossRef CAS PubMed.
  11. K. Guo, T. Fang, J. Wang, A.-A. Wu, Y. Wang, J. Jiang, X. Wu, S. Song, W. Su, Q. Xu and X. Deng, Bioorg. Med. Chem. Lett., 2014, 24, 4995–4998 CrossRef CAS PubMed.
  12. C. B. Nichinde, B. R. Patil, S. S. Chaudhari, B. P. Mali, R. G. Gonnade and A. K. Kinage, RSC Adv., 2023, 13, 13206–13212 RSC.
  13. (a) Q. Wei and L. Z. Gong, Org. Lett., 2010, 12, 1008–1011 CrossRef CAS PubMed; (b) K. Jiang, Z. J. Jia, S. Chen, L. Wu and Y. C. Chen, Chem.–Eur. J., 2010, 16, 2852–2856 CrossRef CAS PubMed; (c) F. Zhong, X. Han, Y. Wang and Y. Lu, Angew. Chem., Int. Ed., 2011, 50, 7837–7841 CrossRef CAS PubMed; (d) V. P. R. Gajulapalli, P. Vinayagam and V. Kesavan, RSC Adv., 2015, 5, 7370–7379 RSC; (e) L.-L. Wang, L. Peng, J.-F. Bai, Q.-C. Huang, X.-Y. Xu and L.-X. Wang, Chem. Commun., 2010, 46, 8064–8066 RSC; (f) Y. B. Lan, H. Zhao, Z. M. Liu, G. G. Liu, J. C. Tao and X. W. Wang, Org. Lett., 2011, 13, 4866–4869 CrossRef CAS PubMed.
  14. (a) X. Companyó, A. Zea, A.-N. R. Alba, A. Mazzanti, A. Moyanoa and R. Rios, Chem. Commun., 2010, 46, 6953–6955 RSC; (b) B. Zhou, Y. Yang, J. Shi, Z. Luo and Y. Li, J. Org. Chem., 2013, 78, 2897–2907 CrossRef CAS PubMed; (c) P.-W. Xu, J.-S. Yu, C. Chen, Z.-Y. Cao, F. Zhou and J. Zhou, ACS Catal., 2019, 9, 1820–1882 CrossRef CAS.
  15. H. Wu and Y.-M. Wang, Chem.–Eur. J., 2014, 20, 5899–5904 CrossRef CAS PubMed.
  16. A. K. Ghosh and B. Zhou, Tetrahedron Lett., 2013, 54, 2311–2314 CrossRef CAS PubMed.
  17. B. R. Thorat, S. N. Mali, S. S. Wavhal, D. S. Bhagat, R. M. Borade, A. Chapolikar, A. Gandhi and P. Shinde, Comb. Chem. High Throughput Screening, 2023, 26, 1108–1140 CrossRef CAS PubMed.
  18. (a) L. He, Z. Tang, L. F. Cun, A. Q. Mi, Y. Z. Jiang and L. Z. Gong, Tetrahedron, 2006, 62, 346–351 CrossRef CAS; (b) B. R. Javle and A. K. Kinage, ChemistrySelect, 2018, 3, 2623–2625 CrossRef CAS.

Footnote

Electronic supplementary information (ESI) available. CCDC 2302588–2302589. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d3ra07652k

This journal is © The Royal Society of Chemistry 2024
Click here to see how this site uses Cookies. View our privacy policy here.